Free Webex Call
The Oxygen Therapy Equipment Market was valued at USD 12.31 Billion in 2024, and is expected to reach USD 17.70 Billion by 2030, rising at a CAGR of 6.20%. Oxygen therapy is a treatment modality for individuals requiring adequate oxygen levels. It is commonly utilized to manage conditions like asthma, Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and others where there is an insufficiency in oxygen supply to patients. Depending on their specific needs, patients can access various types of oxygen therapy such as oxygen concentrators, liquid oxygen, and hyperbaric oxygen therapy. Oxygen therapy, as a medical intervention, employs oxygen gas to deliver acute or chronic patient care, as it plays a crucial role in diverse cell metabolism and optimal physiological function through tissue oxygenation. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
When blood oxygen levels are low, oxygen therapy is employed. It can be administered through different methods, ranging from nasal to hyperbaric oxygen in a closed environment. The respiratory system, consisting of the lungs, nasal passages, and windpipe, facilitates the process of respiration. Air enters the body through the nose or mouth and travels through the windpipe to the lungs via the bronchi. Oxygen therapy equipment is a reliable device that offers a secure supply of oxygen-enriched air. These devices effectively filter room air, removing dust, bacteria, and other particulates to ensure optimal purity.
Key Market Drivers
Surge In the Latest Oxygen Therapy Solutions
The demand for the most minor, durable portable oxygen solutions is rising. Patients are increasingly seeking oxygen therapy options that are not only compact and long-lasting but also easy to carry. This preference arises from their desire to avoid the burden of lugging around a heavy and cumbersome oxygen device. Fortunately, recent years have witnessed significant advancements in oxygen-conserving methods and lithium-ion battery technology, particularly in terms of battery life improvement.The latest versions of portable oxygen concentrators weigh a mere 5-7 pounds. These lightweight devices can provide oxygen therapy for extended periods, ranging from 8 to 13 hours, depending on the litre flow settings chosen by each patient, after a single battery charge. The focus of manufacturers has also shifted towards developing silent compressor motors for these concentrators, thereby reducing noise pollution in small and confined spaces.
Moreover, the effective utilization of dosing technology has enabled portable oxygen concentrator manufacturers to enhance their products' performance features. This, in turn, has resulted in current designs that offer a longer lifespan beyond occasional use, making them more reliable and durable for a consistent five-year cycle. With these advancements and improvements, patients can now enjoy the benefits of portable oxygen therapy without compromising on convenience, reliability, and longevity.
Key Market Challenges
Stringent Regulatory Guidelines
Stringent regulatory guidelines in the healthcare industry have the potential to significantly decrease the demand for oxygen therapy equipment. While regulations are essential for ensuring patient safety and treatment efficacy, an excessively complex or burdensome regulatory environment can create obstacles that hinder innovation, drive up costs, and limit market access for manufacturers and healthcare providers. Rigorous regulatory processes can slow down the introduction of new and improved oxygen therapy equipment to the market. This delay can have serious consequences, as patients may miss out on potentially more effective treatments or innovations that enhance their quality of life. Healthcare providers may also be discouraged from adopting new technologies due to the uncertainties and complexities associated with regulatory approval, further stifling demand.Additionally, stringent guidelines can lead to a limited selection of available equipment, reducing competition and innovation within the industry. This lack of variety can result in fewer options for patients and healthcare professionals, making it harder to find solutions that best meet individual needs. While regulatory guidelines are crucial for ensuring patient safety and treatment effectiveness, excessively stringent regulations can create barriers that diminish the demand for oxygen therapy equipment. Striking the right balance between regulation and innovation is essential to ensure that patients have access to the most advanced and affordable respiratory care solutions.
Key Market Trends
Technology Advancements in Therapeutic Equipment
Due to the significant increase in the number of individuals with respiratory conditions who rely on oxygen therapy devices (OTD), healthcare facilities are facing immense pressure to effectively manage patients who require constant OTD support. This growing demand is driving the market for oxygen therapy solutions. As wearable technology continues to advance, with notable improvements in Photoplethysmography (PPG) sensors and wireless 5G connectivity, it is expected that the trend of digital health data transfer for oxygen therapy monitoring will experience rapid growth.PPG, a non-invasive device, accurately measures volumetric fluctuations in blood circulation by utilizing a light source and a photodetector placed on the skin's surface. Wearable PPG sensors can be comfortably accommodated on specific body parts such as fingertips, earlobes, and the forehead. Moreover, with the increasing utilization and adoption of remote patient monitoring systems, patients are becoming more actively engaged in their own care, thanks to proper instruction in the use of these systems. These advancements and patient involvement hold promising prospects for the market's growth and profitability.
Key Market Players
- Allied Healthcare Products, Inc.
- CAIRE Inc.
- DeVilbiss Healthcare
- Fisher & Paykel Healthcare Limited
- Inogen Inc.
- Invacare Corporation
- Koninklijke Philips N.V.,
- Smith’s Medical, Inc.
- Taiyo Nippon Sanso Corporation
- Linde Healthcare
Report Scope:
In this report, the Global Oxygen Therapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:Oxygen Therapy Equipment Market, By Product Type:
- Oxygen Source Equipment
- Oxygen Delivery Devices
Oxygen Therapy Equipment Market, By Mobility:
- Stationary
- Portable
Oxygen Therapy Equipment Market, By Application:
- COPD
- Lung Cancer
- Pneumonia
- COVID-19
- Others
Oxygen Therapy Equipment Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centres
- Homecare
- Others
Oxygen Therapy Equipment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Oxygen Therapy Equipment Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.Company Information
- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Oxygen Therapy Equipment Market Outlook
6. North America Oxygen Therapy Equipment Market Outlook
7. Europe Oxygen Therapy Equipment Market Outlook
8. Asia-Pacific Oxygen Therapy Equipment Market Outlook
9. South America Oxygen Therapy Equipment Market Outlook
10. Middle East and Africa Oxygen Therapy Equipment Market Outlook
11. Market Dynamics
12. Market Trends & Developments
14. Competitive Landscape
Companies Mentioned
- Allied Healthcare Products, Inc.
- CAIRE Inc.
- DeVilbiss Healthcare
- Fisher & Paykel Healthcare Limited
- Inogen Inc.
- Invacare Corporation
- Koninklijke Philips N.V.,
- Smith’s Medical, Inc.
- Taiyo Nippon Sanso Corporation
- Linde Healthcare
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 185 |
Published | August 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 12.31 Billion |
Forecasted Market Value ( USD | $ 17.7 Billion |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |